Robert F. Kennedy Jr. promised to drain the swamp. He told voters he would shut the revolving door between industry and government. He repeated that pledge throughout his confirmation hearings.
Four months later, the CDC has a former Big Tobacco executive in a senior leadership role and a suppressed vaccine study sitting in a rejection file. Both in the same week. Both on his watch.
This is not dysfunction. This is the plan working exactly as intended.
A Tobacco Lobbyist Now Runs CDC Legislative Affairs
Stephen Sayle is the CDC's new Deputy Director for Legislative Affairs. Before joining the agency, Sayle served as U.S. Vice President of Corporate Affairs at Fontem Ventures, a subsidiary of Imperial Brands, one of the world's largest tobacco corporations. Fontem makes e-cigarettes and oral nicotine pouches under brand names including blu and Zone.
Before that, Sayle lobbied for Chevron and other energy companies. The man now shaping what Congress hears from the CDC spent his career as a hired gun for two of the industries most hostile to public health regulation.
The appointment drew an immediate rebuke from Timothy McAfee, who ran the CDC's Office of Smoking and Health from 2010 to 2017. McAfee called Sayle's hire "unprecedented" in an editorial published this week in the journal Tobacco Control. He told STAT News the appointment is also "completely inconsistent" with Kennedy's own pledges to stop the revolving door.
"Completely inconsistent with RFK Jr.'s previous pledges to shut the revolving door between industry and government." — Timothy McAfee, former CDC Office of Smoking and Health director, in Tobacco Control
The Deputy Director for Legislative Affairs shapes the CDC's relationship with Congress, including on tobacco and nicotine regulation. Sayle is now the person briefing lawmakers on the agency's position on the exact industry he worked for. That is not a coincidence. That is how revolving doors work.
The CDC Buried a Vaccine Study. The Findings: Vaccines Work.
On April 22, 2026, the Washington Post and CNN both reported that the CDC had formally blocked publication of a study in its flagship scientific journal, the Morbidity and Mortality Weekly Report (MMWR).
The study's conclusion: COVID vaccines reduced emergency department visits and hospitalizations among healthy adults by approximately 50 percent during the winter of 2025-26.
The paper had cleared the CDC's full internal scientific review, a process involving dozens of scientists. It was scheduled for publication on March 19, 2026. Acting CDC Director Jay Bhattacharya first delayed it. By April 22, a formal rejection letter had been sent to the report's authors.
Three people with direct knowledge of the decision told reporters the blockage was political. Current and former CDC officials called it extraordinarily rare: the MMWR has functioned as an independent scientific publication for more than 70 years. Papers do not get rejected after clearing full review. They certainly do not get rejected because the findings are inconvenient to the secretary who appointed the acting director.
Kennedy has publicly opposed COVID vaccines for years. Bhattacharya, the Stanford professor Kennedy installed as acting director, co-authored the Great Barrington Declaration, which argued against COVID protective measures at the height of the pandemic. The study showed vaccines reduce hospitalizations. The study did not get published.
Two Moves. One Agency. One Direction.
The tobacco hire and the suppressed vaccine study are not two separate stories. They are the same story told twice in the same week.
One move installs an industry loyalist in a position that manages the CDC's congressional relationships. The other suppresses scientific data that contradicts the ideological preferences of the people now running the agency. Both moves serve the same purpose: converting the CDC from a science institution into a political instrument.
Public health depends on trust. Trust requires institutional independence. Independence requires that health agencies are not staffed by the lobbyists of the industries they oversee. It requires that studies are published when they clear scientific review, not when they confirm what the secretary already believes.
Neither condition currently holds at the CDC.
Why This Matters Beyond the Headlines
Millions of Americans consult CDC guidance to make decisions about their health and their children's health. Physicians reference MMWR findings. State health departments use CDC data to allocate resources. School boards cite CDC guidance on vaccines.
When the CDC puts a tobacco lobbyist in a legislative leadership role and buries a vaccine effectiveness study in the same week, the consequences extend well past the politics. People making health decisions with incomplete or politically filtered information face real risks.
Kennedy did not drain the swamp. He restocked it and handed out the fishing permits himself.
Sources
- Former tobacco executive joins CDC senior leadership, raising concerns over industry influence — STAT News
- Former Tobacco Executive Takes CDC Role — U.S. News & World Report
- CDC won't publish report showing COVID shots cut likelihood of hospital visits — Washington Post
- HHS rejects publication of study showing Covid-19 vaccines prevent hospitalizations, ER visits — CNN
- Leaked CDC Report Reveals RFK Jr. Officials Blocked Flagship Medical Journal From Publishing Positive Covid Vaccine Data — HNGN
Independent. Unfiltered. Unbought.
This is independent, sourced accountability reporting by Impeach 47. No corporate owners, no paywall.
Get new posts delivered free by email: impeachh47.substack.com.
Follow on X: @Impeach_47.
If this reporting is useful, the way you support us is simple: wear the movement. Every hat, shirt, and sticker from impeach47.earth is a walking billboard and the thing that keeps this research fed.
0 comments